Advancing our innovative pipeline
to address unmet needs

Archived Publications

> TransCon Growth Hormone
> TransCon PTH
> TransCon CNP
> Selected Publications

TransCon Growth Hormone

Pediatric Phase 2 Data Demonstrate That TransCon hGH Has an Anti-hGH Immunogenic Profile That Is Comparable to Daily hGH
D. Gilfoyle, S. Pihl, P. Chatelain, M. Beckert. Poster presented at 55th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE), September 10-12, 2016 (Paris, France).

A Six-Month Safety and Efficacy Study of TransCon hGH Compared to Daily hGH in Prepubertal Children with Growth Hormone Deficiency (GHD)
P. Chatelain, O. Malievsky, K. Radziuk, G. Senatorova, M. Beckert. Poster presented at 55th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE), September 10-12, 2016 (Paris, France).

Design and Clinical Development of TransCon Growth Hormone for Growth Hormone Deficiency
M. Beckert, D. Gilfoyle, J.M. Mikkelsen, et al. Poster presented at 55th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE), September 10-12, 2016 (Paris, France).

Pharmacokinetic Modelling Predicts Native hGH Levels Following Administration of a Sustained-release Prodrug, TransCon hGH, to Children With GHD
K. Sprog√łe, M. Beckert, E.D. Christoffersen, D. Gilfoyle, T. Wegge. Poster presented at 55th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE), September 10-12, 2016 (Paris, France).

 

Back to Top